Login

Insights for a Different World: Arjan Meijer on Aviation's Future | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Impact of FTC and DOJ Changes on Middle Market Transactions
00:10:00
Understanding Your Balance Sheet: A Simple Guide
00:10:00
Investing in Turbulent Times: Insights from Industry Leaders | John Koudounis, CEO , Calamos Investments LLC.
00:10:00
B&W's ClimateBright™: Building a Clean Energy Future | Kenneth Young - CEO of Babcock & Wilcox
00:10:00
"Scott Kleinman of Apollo Management on Market Sentiment, Fed Policy, and Global Outlook"
00:00:00
Science Matters with Jeremy Gunawardena / Jeremy Gunawardena Associate Professor of Systems Biology, HMS
00:10:00
BLADE CEO Rob Wiesenthal discusses Blade Air Mobility and BETA Technologies' groundbreaking Electric Vertical Aircraft flight with CNBC.|Rob Wiesenthal, CEO of Blade Air Mobility
00:10:00
30 Years of Trust: Beyond Investing, Building Relationships
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Helps the new farm so that daring build legendary companies|Doug Leone,Global Managing Partner,Sequoia Capital
00:10:00
Investors in virtual reality, augmented reality and blockchain technologies|Ryan Wang,Co-founder and General Partner,Outpost Capital
00:10:00
Exploring the IDFC US Equity Fund of Fund: Insights from Sirshendu Basu | Sirshendu Basu - Fund Manager, IDFC AMC

© 2026 Nehu